{
  "url": "https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_settlements",
  "title": "List of largest pharmaceutical settlements",
  "header": [
    [
      [
        "Year"
      ],
      [
        null
      ]
    ],
    [
      [
        "Company"
      ],
      [
        null
      ]
    ],
    [
      [
        "Settlement"
      ],
      [
        null
      ]
    ],
    [
      [
        "Violation(s)"
      ],
      [
        null
      ]
    ],
    [
      [
        "Product(s)"
      ],
      [
        null
      ]
    ],
    [
      [
        "Laws allegedly violated (if applicable)"
      ],
      [
        null
      ]
    ]
  ],
  "data": [
    [
      [
        [
          "2012"
        ],
        [
          null
        ]
      ],
      [
        [
          "GlaxoSmithKline"
        ],
        [
          "/wiki/GlaxoSmithKline"
        ]
      ],
      [
        [
          "$3 billion ($1B criminal, $2B civil)"
        ],
        [
          null
        ]
      ],
      [
        [
          "Medicaid Drug Rebate Program"
        ],
        [
          "/wiki/Medicaid_Drug_Rebate_Program"
        ]
      ],
      [
        [
          "Avandia",
          "Wellbutrin",
          "Paxil",
          "Advair",
          "Lamictal",
          "Zofran",
          "Imitrex",
          "Lotronex",
          "Flovent",
          "Valtrex"
        ],
        [
          "/wiki/Rosiglitazone",
          "/wiki/Bupropion",
          "/wiki/Paroxetine",
          "/wiki/Advair",
          "/wiki/Lamictal",
          "/wiki/Zofran",
          "/wiki/Imitrex",
          "/wiki/Lotronex",
          "/wiki/Flovent",
          "/wiki/Valtrex"
        ]
      ],
      [
        [
          "False Claims Act",
          "FDCA"
        ],
        [
          "/wiki/False_Claims_Act",
          "/wiki/Federal_Food,_Drug,_and_Cosmetic_Act"
        ]
      ]
    ],
    [
      [
        [
          "2009"
        ],
        [
          null
        ]
      ],
      [
        [
          "Pfizer"
        ],
        [
          "/wiki/Pfizer"
        ]
      ],
      [
        [
          "$2.3 billion"
        ],
        [
          null
        ]
      ],
      [
        [
          "kickbacks"
        ],
        [
          "/wiki/Kickback_(bribery)"
        ]
      ],
      [
        [
          "Bextra",
          "Geodon",
          "Zyvox",
          "Lyrica"
        ],
        [
          "/wiki/Valdecoxib",
          "/wiki/Ziprasidone",
          "/wiki/Linezolid",
          "/wiki/Pregabalin"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2013"
        ],
        [
          null
        ]
      ],
      [
        [
          "Johnson & Johnson"
        ],
        [
          "/wiki/Johnson_%26_Johnson"
        ]
      ],
      [
        [
          "$2.2 billion"
        ],
        [
          null
        ]
      ],
      [
        [
          "kickbacks"
        ],
        [
          "/wiki/Kickback_(bribery)"
        ]
      ],
      [
        [
          "Risperdal",
          "Invega",
          "Nesiritide"
        ],
        [
          "/wiki/Risperidone",
          "/wiki/Paliperidone",
          "/wiki/Nesiritide"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2012"
        ],
        [
          null
        ]
      ],
      [
        [
          "Abbott Laboratories"
        ],
        [
          "/wiki/Abbott_Laboratories"
        ]
      ],
      [
        [
          "$1.5 billion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Depakote"
        ],
        [
          "/wiki/Valproic_acid"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2009"
        ],
        [
          null
        ]
      ],
      [
        [
          "Eli Lilly"
        ],
        [
          "/wiki/Eli_Lilly_and_Company"
        ]
      ],
      [
        [
          "$1.4 billion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Zyprexa"
        ],
        [
          "/wiki/Olanzapine"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2001"
        ],
        [
          null
        ]
      ],
      [
        [
          "TAP Pharmaceutical Products"
        ],
        [
          "/wiki/TAP_Pharmaceutical_Products"
        ]
      ],
      [
        [
          "$875 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Medicare fraud"
        ],
        [
          "/wiki/Medicare_fraud"
        ]
      ],
      [
        [
          "Lupron"
        ],
        [
          "/wiki/Leuprorelin"
        ]
      ],
      [
        [
          "Prescription Drug Marketing Act"
        ],
        [
          "/wiki/Prescription_Drug_Marketing_Act"
        ]
      ]
    ],
    [
      [
        [
          "2012"
        ],
        [
          null
        ]
      ],
      [
        [
          "Amgen"
        ],
        [
          "/wiki/Amgen"
        ]
      ],
      [
        [
          "$762 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion/kickbacks"
        ],
        [
          null
        ]
      ],
      [
        [
          "Aranesp"
        ],
        [
          "/wiki/Aranesp"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2010"
        ],
        [
          null
        ]
      ],
      [
        [
          "GlaxoSmithKline"
        ],
        [
          null
        ]
      ],
      [
        [
          "$750 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Poor manufacturing practices"
        ],
        [
          null
        ]
      ],
      [
        [
          "Kytril",
          "Bactroban",
          "Paxil CR",
          "Avandamet"
        ],
        [
          "/wiki/Granisetron",
          "/wiki/Mupirocin",
          "/wiki/Paroxetine",
          "/wiki/Metformin"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2005"
        ],
        [
          null
        ]
      ],
      [
        [
          "Serono"
        ],
        [
          "/wiki/Serono"
        ]
      ],
      [
        [
          "$704 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "monopoly"
        ],
        [
          "/wiki/Monopoly"
        ]
      ],
      [
        [
          "Serostim"
        ],
        [
          "/wiki/Serostim"
        ]
      ],
      [
        [
          "False Claims Act"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2008"
        ],
        [
          null
        ]
      ],
      [
        [
          "Merck"
        ],
        [
          "/wiki/Merck_%26_Co."
        ]
      ],
      [
        [
          "$650 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Medicare fraud/kickbacks"
        ],
        [
          null
        ]
      ],
      [
        [
          "Zocor",
          "Vioxx",
          "Pepsid"
        ],
        [
          "/wiki/Simvastatin",
          "/wiki/Rofecoxib",
          "/wiki/Famotidine"
        ]
      ],
      [
        [
          "False Claims Act/ Medicaid Rebate Statute"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2007"
        ],
        [
          null
        ]
      ],
      [
        [
          "Purdue Pharma"
        ],
        [
          "/wiki/Purdue_Pharma"
        ]
      ],
      [
        [
          "$601 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Oxycontin"
        ],
        [
          "/wiki/Oxycontin"
        ]
      ],
      [
        [
          "False Claims Act"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2010"
        ],
        [
          null
        ]
      ],
      [
        [
          "Allergan"
        ],
        [
          "/wiki/Allergan"
        ]
      ],
      [
        [
          "$600 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Botox"
        ],
        [
          "/wiki/Botulinum_toxin"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2010"
        ],
        [
          null
        ]
      ],
      [
        [
          "AstraZeneca"
        ],
        [
          "/wiki/AstraZeneca"
        ]
      ],
      [
        [
          "$520 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion/kickbacks"
        ],
        [
          null
        ]
      ],
      [
        [
          "Seroquel"
        ],
        [
          "/wiki/Quetiapine"
        ]
      ],
      [
        [
          "False Claims Act"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2007"
        ],
        [
          null
        ]
      ],
      [
        [
          "Bristol-Myers Squibb"
        ],
        [
          "/wiki/Bristol-Myers_Squibb"
        ]
      ],
      [
        [
          "$515 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion/ kickbacks/Medicare fraud"
        ],
        [
          null
        ]
      ],
      [
        [
          "Abilify",
          "Serzone"
        ],
        [
          "/wiki/Aripiprazole",
          "/wiki/Nefazodone"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2002"
        ],
        [
          null
        ]
      ],
      [
        [
          "Schering-Plough"
        ],
        [
          "/wiki/Schering-Plough"
        ]
      ],
      [
        [
          "$500 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Poor manufacturing practices"
        ],
        [
          null
        ]
      ],
      [
        [
          "Claritin"
        ],
        [
          "/wiki/Loratadine"
        ]
      ],
      [
        [
          "FDA",
          "Good Manufacturing Practices"
        ],
        [
          "/wiki/Food_and_Drug_Administration",
          "/wiki/Good_manufacturing_practice"
        ]
      ]
    ],
    [
      [
        [
          "2006"
        ],
        [
          null
        ]
      ],
      [
        [
          "Mylan"
        ],
        [
          "/wiki/Mylan"
        ]
      ],
      [
        [
          "$465 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Medicaid Drug Rebate Program"
        ],
        [
          "/wiki/Medicaid_Drug_Rebate_Program"
        ]
      ],
      [
        [
          "EpiPen",
          "epinephrine"
        ],
        [
          "/wiki/EpiPen",
          "/wiki/Epinephrine"
        ]
      ],
      [
        [
          "False Claims Act"
        ],
        [
          "/wiki/False_Claims_Act"
        ]
      ]
    ],
    [
      [
        [
          "2006"
        ],
        [
          null
        ]
      ],
      [
        [
          "Schering-Plough"
        ],
        [
          null
        ]
      ],
      [
        [
          "$435 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion/ kickbacks/Medicare fraud"
        ],
        [
          null
        ]
      ],
      [
        [
          "Temodar",
          "Intron A",
          "K-Dur",
          "Claritin RediTabs"
        ],
        [
          "/wiki/Temozolomide",
          "/wiki/Interferon_alfa-2b",
          "/wiki/Potassium_chloride",
          "/wiki/Loratadine"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2004"
        ],
        [
          null
        ]
      ],
      [
        [
          "Pfizer"
        ],
        [
          null
        ]
      ],
      [
        [
          "$430 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Neurontin"
        ],
        [
          "/wiki/Gabapentin"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2008"
        ],
        [
          null
        ]
      ],
      [
        [
          "Cephalon"
        ],
        [
          "/wiki/Cephalon"
        ]
      ],
      [
        [
          "$425 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion"
        ],
        [
          null
        ]
      ],
      [
        [
          "Actiq",
          "Gabitril",
          "Provigil"
        ],
        [
          "/wiki/Actiq",
          "/wiki/Tiagabine",
          "/wiki/Modafinil"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "2010"
        ],
        [
          null
        ]
      ],
      [
        [
          "Novartis"
        ],
        [
          "/wiki/Novartis"
        ]
      ],
      [
        [
          "$423 million"
        ],
        [
          null
        ]
      ],
      [
        [
          "Off-label promotion/kickbacks"
        ],
        [
          null
        ]
      ],
      [
        [
          "Trileptal"
        ],
        [
          "/wiki/Oxcarbazepine"
        ]
      ],
      [
        [
          "False Claims Act/FDCA"
        ],
        [
          null
        ]
      ]
    ]
  ],
  "context": "",
  "idx": 277
}